Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05627219 · ClinicalTrials.gov registry record

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

A clinical trial of Metastatic Prostate Carcinoma and Stage IV Prostate Cancer AJCC v8, sponsored by Thomas Jefferson University.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT05627219 is a study of Metastatic Prostate Carcinoma and Stage IV Prostate Cancer AJCC v8 that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 30 participants, below the 132-participant average among 37 other Metastatic Prostate Carcinoma trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05627219, a study of Metastatic Prostate Carcinoma and Stage IV Prostate Cancer AJCC v8, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

This trial evaluates whether a network of peer genetic coaches is useful for addressing disparities in genetic testing and screening among African American men with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). While genetic testing has become central to prostate cancer care, African American men are less likely seek testing due to lack of awareness, cultural beliefs, financial limitations, fear of discrimination, and mistrust in the healthcare system. A network of peer genetic coaches may help address barriers, beliefs, and needs of African American men in the community and provide navigation to increase engagement in genetic testing.

Conditions Studied

Metastatic Prostate Carcinoma Stage IV Prostate Cancer AJCC v8 Stage IIIB Prostate Cancer AJCC v8 Stage IIIC Prostate Cancer AJCC v8

Interventions

  • OTHER Educational Intervention
  • PROCEDURE Discussion
  • BEHAVIORAL Training and Education

Study Locations (1)

Pennsylvania

  • Sidney Kimmel Cancer Center at Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-06-03
Est. Completion 2026-04-29

Sponsor

Thomas Jefferson University

292 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05627219

The ClinicalTrials.gov registry entry for NCT05627219 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 132-participant average among 37 other Metastatic Prostate Carcinoma trials with a reported enrollment target (77% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Metastatic Prostate Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Educational Intervention is the first listed.

NCT05627219 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05627219 about?

NCT05627219 is a clinical study titled "Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network". This trial evaluates whether a network of peer genetic coaches is useful for addressing disparities in genetic testing and screening among African American men with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). While genetic test...

What is the current status of trial NCT05627219?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-06-03. Estimated completion is 2026-04-29.

What conditions does trial NCT05627219 study?

This clinical trial studies the following conditions: Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8.

What interventions are being tested in trial NCT05627219?

The interventions under investigation include: Educational Intervention (OTHER), Discussion (PROCEDURE), Training and Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT05627219?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05627219 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Metastatic Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Metastatic Prostate Carcinoma

All registered trials for this condition

Stage IV Prostate Cancer AJCC v8

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.